| Parkinson’s disease: clinical features and diagnosis J Jankovic Journal of neurology, neurosurgery & psychiatry 79 (4), 368-376, 2008 | 6939 | 2008 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6292 | 2008 |
| Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) report of the NINDS-SPSP international workshop I Litvan, Y Agid, D Calne, G Campbell, B Dubois, RC Duvoisin, CG Goetz, ... Neurology 47 (1), 1-9, 1996 | 2781 | 1996 |
| Phenomenology and classification of dystonia: a consensus update A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ... Movement disorders 28 (7), 863-873, 2013 | 2330 | 2013 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2264 | 2004 |
| Unified Huntington's disease rating scale: reliability and consistency K Kieburtz, JB Penney, P Como, N Ranen, A Feigin, D Abwender, ... Movement disorders 11 (2), 136-142, 1996 | 1982 | 1996 |
| Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, ... Neurology 40 (10), 1529-1529, 1990 | 1566 | 1990 |
| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1530 | 2019 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ... Movement disorders 22 (1), 41-47, 2007 | 1504 | 2007 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1486 | 2011 |
| Therapeutic uses of botulinum toxin J Jankovic, MF Brin New England Journal of Medicine 324 (17), 1186-1194, 1991 | 1137 | 1991 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ... New England Journal of Medicine 361 (13), 1268-1278, 2009 | 1044 | 2009 |
| Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD JG Nutt, KJ Burchiel, CL Comella, J Jankovic, AE Lang, ER Laws Jr, ... Neurology 60 (1), 69-73, 2003 | 901 | 2003 |
| Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 856 | 2017 |
| Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy Consensus Committee of the American Autonomic Society and the American ... Neurology 46 (5), 1470-1470, 1996 | 831* | 1996 |
| How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the … GT Stebbins, CG Goetz, DJ Burn, J Jankovic, TK Khoo, BC Tilley Movement Disorders 28 (5), 668-670, 2013 | 765 | 2013 |
| Tourette's syndrome J Jankovic New England Journal of Medicine 345 (16), 1184-1192, 2001 | 732* | 2001 |
| DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease Z Hong, M Shi, KA Chung, JF Quinn, ER Peskind, D Galasko, J Jankovic, ... Brain 133 (3), 713-726, 2010 | 725 | 2010 |
| Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial WJ Marks, RT Bartus, J Siffert, CS Davis, A Lozano, N Boulis, J Vitek, ... The Lancet Neurology 9 (12), 1164-1172, 2010 | 714 | 2010 |
| Parkinson’s disease: etiopathogenesis and treatment J Jankovic, EK Tan Journal of Neurology, Neurosurgery & Psychiatry 91 (8), 795-808, 2020 | 694 | 2020 |
